Alterity Therapeutics Ltd ADR (ATHE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2018 | 12-2017 | 06-2017 | 12-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,408 | N/A | -5,680 | -2,730 | -5,632 |
| Depreciation Amortization | 17 | N/A | 10 | 8 | 17 |
| Other Working Capital | 826 | N/A | 660 | 2,670 | 877 |
| Other Operating Activity | 723 | -900 | 590 | -408 | -667 |
| Operating Cash Flow | $-4,842 | $-900 | $-4,420 | $-460 | $-5,405 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -48 | -3 | -20 | -10 | -2 |
| Other Investing Activity | 34 | 0 | 0 | 0 | 1 |
| Investing Cash Flow | $-14 | $-3 | $-20 | $-10 | $-1 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -84 | -20 | -120 | -110 | 0 |
| Financing Cash Flow | $-84 | $-20 | $-120 | $-110 | $0 |
| Exchange Rate Effect | -216 | -460 | -490 | 400 | 804 |
| Beginning Cash Position | 16,967 | 16,710 | 21,550 | 21,410 | 25,435 |
| End Cash Position | 11,812 | 15,310 | 16,490 | 21,220 | 20,833 |
| Net Cash Flow | $-5,155 | $-1,400 | $-5,050 | $-180 | $-4,602 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,842 | -900 | -4,420 | -460 | -5,405 |
| Free Cash Flow | -4,842 | -900 | -4,420 | -460 | -5,405 |